Navigating the Tech Transfer Process
Tuesday, November 30, 2010
The New York Academy of Sciences
Presented by the Science Alliance
You have a patentable idea and think there is a large market for this technology; now you must be able to navigate the university tech transfer or tech commercialization office. David Anthony, venture capitalist, who has licensed over a dozen patents from universities and research labs across the world, will lead a discussion on the complex, and often frustrating, process of technology transfer. This session aims to educate academic researchers on the role of the tech transfer office in the commercialization process and highlight some of the challenges encountered by both scientists and tech transfer officers in order to enhance the communication between these two groups. Local tech transfer officers will contribute to the discussion.
This is the third event of a four part series.
Science, Technology, and Intellectual Property, November 2, 2010
Evaluating Opportunity for a Tech Venture, November 16, 2010
Navigating the Tech Transfer Process, November 30, 2010
Business Plan: Inception to Fruition, December 14, 2010
These events will also be broadcast as webinars. You may purchase all four events (onsite or webinar) at a discount or register only for the individual events you are interested in.
Please note if you register for all four events, you must either attend all onsite or all as webinars.
Transmission of presentations via the webinar is subject to individual consent by the speakers. Therefore, we cannot guarantee that every speaker's presentation will be broadcast in full via the webinar. To access all speakers' presentations in full, we invite you to attend the live event in New York City where possible.
David Anthony, MBA
David Anthony is an experienced entrepreneur, venture capitalist, and educator. Since founding 21Ventures in 2004, the firm has provided seed, growth, and bridge capital to over 40 technology ventures across the globe focusing mainly in the cleantech arena. David Anthony sits on the board of a number of 21V portfolio companies including (partial list) Advanced Telemetry; BioPetroClean, ETV Motors, and Variable Wind Solutions. David also serves on the board of directors of publicly traded companies Axion Power International, Inc. (OTC: AXPW); Clean Power Technologies Inc. (OTC: CPWE) Solar EnerTech Corp. (OTC: ENSL), Energy Focus, Inc.(NASDAQ: EFOI) and ThermoEnergy Corporation (OTC: TMEN).
Previously, Mr. Anthony collaborated with Dartmouth College professor Dr. John K. Shank and consulted for Fortune 500 clients on capital investments, mergers and acquisitions, and entrepreneurship. In addition David is an adjunct professor at the NYU Stern School of business where he began teaching technology entrepreneurship in the Fall of 2009. David has taught Idea to IPO at The Academy since 2004.
David received his MBA from The Tuck School of Business at Dartmouth College in 1989 and a BA in economics from George Washington University in 1982. He is an entrepreneurship mentor at the Land Center for Entrepreneurship at Columbia University Graduate School of Business. In 2002, David was awarded the Distinguished Mentor of the Year Award from Columbia University.
Andrew Koopman, MS
New York University
Andrew is currently Manager, New Venture Development in the Office of Industrial Liaison/Technology Transfer at NYU. His responsibilities include due diligence for the patentability and commercial potential of early stage technologies in the life sciences, along with marketing and licensing such technologies and intellectual property strategies. He has been involved in the formation of several new companies that focus on the development and commercialization of innovative medical technologies.
Andrew began his career in biotechnology as a scientist at Unigene Laboratories, a small, contract research based biotechnology company that went through the IPO process during his tenure. He then moved on to Ortho Diagnostic Systems where he was involved in the collaboration between Johnson& Johnson and Enzo Biochem to develop DNA based diagnostics. Continuing in this field, he then went to Hoffman La Roche to become one of the first members of a new division, formed to develop and commercialize the PCR technology that had been purchased by Roche for more than $350 million. As a project manager, he brought numerous products through the FDA approval process and into the marketplace. Andrew then joined the merchant investment banking and strategic advisory group of Beroff Associates as Managing Director of Biomedical and Biotechnology Industries.
Andrew earned a B.S. in Biology from SUNY Binghamton and an M.S. in molecular biology with a graduate minor in business from the Stillman School of Business at Seton Hall University.
Travel & Lodging
The New York Academy of Sciences
7 World Trade Center
250 Greenwich Street, 40th floor
New York, NY 10007-2157
Hotels Near 7 World Trade Center
Recommended partner hotel:
The New York Academy of Sciences is a part of the Club Quarters network . Please feel free to make accommodations with Club Quarters on-line to save significantly on hotel costs.
Club Quarters Reservation Password: NYAS
Club Quarters, World Trade Center
140 Washington Street
New York, NY 10006
Phone: (212) 577-1133
Located on the south side of the World Trade Center, opposite Memorial Plaza, Club Quarters, 140 Washington Street, is just a short walk to our location.
Other hotels located near 7 WTC: